Some studies with a monoclonal antibody directed against human fibrinogen
Some properties of a monoclonal antibody generated against the fibrinogen component of a factor VIII preparation were investigated. The antibody bound with equal affinity in solid phase radioimmunoassays to fibrinogens isolated from both normal patients and patients with von Willebrand disease. It r...
Gespeichert in:
Veröffentlicht in: | American journal of hematology 1985-02, Vol.18 (2), p.111-119 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 119 |
---|---|
container_issue | 2 |
container_start_page | 111 |
container_title | American journal of hematology |
container_volume | 18 |
creator | Francis, Susan E. Joshua, Douglas E. Exner, Thomas Kronenberg, Harry |
description | Some properties of a monoclonal antibody generated against the fibrinogen component of a factor VIII preparation were investigated. The antibody bound with equal affinity in solid phase radioimmunoassays to fibrinogens isolated from both normal patients and patients with von Willebrand disease. It reacted in a sensitive immunoassay of plasma fibrinogen. The specificity of the antibody was confined to the parent molecule with no significant inhibition of fibrinogen binding by the fibrinogen degradation products (FDPs) X, Y, D, or E. The antibody had no significant effect on the activated partial thromboplastin time and prothrombin time of normal plasma. However, it prolonged the thrombin time as determined by the Clauss chronometric fibrinogen method. During fibrinogen lysis by plasmin immunoreactivity of fibrinogen to the antibody was lost at the same rate as the clottable fibrinogen content determined by the Clauss assay. The lack of reactivity of the antibody with FDPs makes it a suitable reagent for investigating plasmin activity as well as studying fibrinogen and fibrin. These findings suggest that the epitope of the antibody lies within the polar protruberance of the carboxy terminal end of the Aα chain of fibrinogen and is destroyed by plasmin cleavage. |
doi_str_mv | 10.1002/ajh.2830180202 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75975686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>75975686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3692-a3d804962c27bb93a5338561921a8489f75704384fdc1c238fba465d184981983</originalsourceid><addsrcrecordid>eNqFkM1Lw0AQxRdRaq1evQl7EG-p-5Fsdo9F1FYKHtRzmGw27ZZkt2YTSv97UxqqN2FgBt5v5g0PoVtKppQQ9gib9ZRJTqgkjLAzNKZEiUiKhJ2jMeGC9jNRl-gqhA0hlMaSjNCIJalMORmjxYevDQ5tV1gT8M62awy49s7ryjuoMLjW5r7Y48I2RremwLAC60KL110NDpc2b6zzK-Ou0UUJVTA3Q5-gr5fnz6d5tHx_XTzNlpHmQrEIeCFJrATTLM1zxSHhXCaCKkZBxlKVaZKSmMu4LDTVjMsyh1gkBZWxklRJPkEPx7vbxn93JrRZbYM2VQXO-C5kaaLSREjRg9MjqBsfQmPKbNvYGpp9Rkl2yC7rs8t-s-sX7obLXV6b4oQPYfX6_aBD0FCVDThtwwlTjPd18FVHbGcrs__HNJu9zf-88AN0UIXL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75975686</pqid></control><display><type>article</type><title>Some studies with a monoclonal antibody directed against human fibrinogen</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Francis, Susan E. ; Joshua, Douglas E. ; Exner, Thomas ; Kronenberg, Harry</creator><creatorcontrib>Francis, Susan E. ; Joshua, Douglas E. ; Exner, Thomas ; Kronenberg, Harry</creatorcontrib><description>Some properties of a monoclonal antibody generated against the fibrinogen component of a factor VIII preparation were investigated. The antibody bound with equal affinity in solid phase radioimmunoassays to fibrinogens isolated from both normal patients and patients with von Willebrand disease. It reacted in a sensitive immunoassay of plasma fibrinogen. The specificity of the antibody was confined to the parent molecule with no significant inhibition of fibrinogen binding by the fibrinogen degradation products (FDPs) X, Y, D, or E. The antibody had no significant effect on the activated partial thromboplastin time and prothrombin time of normal plasma. However, it prolonged the thrombin time as determined by the Clauss chronometric fibrinogen method. During fibrinogen lysis by plasmin immunoreactivity of fibrinogen to the antibody was lost at the same rate as the clottable fibrinogen content determined by the Clauss assay. The lack of reactivity of the antibody with FDPs makes it a suitable reagent for investigating plasmin activity as well as studying fibrinogen and fibrin. These findings suggest that the epitope of the antibody lies within the polar protruberance of the carboxy terminal end of the Aα chain of fibrinogen and is destroyed by plasmin cleavage.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.2830180202</identifier><identifier>PMID: 2578730</identifier><identifier>CODEN: AJHEDD</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Antibodies, Monoclonal - immunology ; Antibodies, Monoclonal - pharmacology ; Antibody Specificity ; Anticoagulants ; Biological and medical sciences ; Epitopes ; fibrin ; Fibrin Fibrinogen Degradation Products - immunology ; fibrinogen ; Fibrinogen - immunology ; Fibrinolysin - pharmacology ; Humans ; Immunological methods for diagnosis and exploration ; Immunopathology ; Medical sciences ; monoclonal antibody ; Other methods ; Radioimmunoassay ; von Willebrand Diseases - immunology</subject><ispartof>American journal of hematology, 1985-02, Vol.18 (2), p.111-119</ispartof><rights>Copyright © 1985 Wiley‐Liss, Inc., A Wiley Company</rights><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3692-a3d804962c27bb93a5338561921a8489f75704384fdc1c238fba465d184981983</citedby><cites>FETCH-LOGICAL-c3692-a3d804962c27bb93a5338561921a8489f75704384fdc1c238fba465d184981983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.2830180202$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.2830180202$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9239236$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2578730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Francis, Susan E.</creatorcontrib><creatorcontrib>Joshua, Douglas E.</creatorcontrib><creatorcontrib>Exner, Thomas</creatorcontrib><creatorcontrib>Kronenberg, Harry</creatorcontrib><title>Some studies with a monoclonal antibody directed against human fibrinogen</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>Some properties of a monoclonal antibody generated against the fibrinogen component of a factor VIII preparation were investigated. The antibody bound with equal affinity in solid phase radioimmunoassays to fibrinogens isolated from both normal patients and patients with von Willebrand disease. It reacted in a sensitive immunoassay of plasma fibrinogen. The specificity of the antibody was confined to the parent molecule with no significant inhibition of fibrinogen binding by the fibrinogen degradation products (FDPs) X, Y, D, or E. The antibody had no significant effect on the activated partial thromboplastin time and prothrombin time of normal plasma. However, it prolonged the thrombin time as determined by the Clauss chronometric fibrinogen method. During fibrinogen lysis by plasmin immunoreactivity of fibrinogen to the antibody was lost at the same rate as the clottable fibrinogen content determined by the Clauss assay. The lack of reactivity of the antibody with FDPs makes it a suitable reagent for investigating plasmin activity as well as studying fibrinogen and fibrin. These findings suggest that the epitope of the antibody lies within the polar protruberance of the carboxy terminal end of the Aα chain of fibrinogen and is destroyed by plasmin cleavage.</description><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antibody Specificity</subject><subject>Anticoagulants</subject><subject>Biological and medical sciences</subject><subject>Epitopes</subject><subject>fibrin</subject><subject>Fibrin Fibrinogen Degradation Products - immunology</subject><subject>fibrinogen</subject><subject>Fibrinogen - immunology</subject><subject>Fibrinolysin - pharmacology</subject><subject>Humans</subject><subject>Immunological methods for diagnosis and exploration</subject><subject>Immunopathology</subject><subject>Medical sciences</subject><subject>monoclonal antibody</subject><subject>Other methods</subject><subject>Radioimmunoassay</subject><subject>von Willebrand Diseases - immunology</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1Lw0AQxRdRaq1evQl7EG-p-5Fsdo9F1FYKHtRzmGw27ZZkt2YTSv97UxqqN2FgBt5v5g0PoVtKppQQ9gib9ZRJTqgkjLAzNKZEiUiKhJ2jMeGC9jNRl-gqhA0hlMaSjNCIJalMORmjxYevDQ5tV1gT8M62awy49s7ryjuoMLjW5r7Y48I2RremwLAC60KL110NDpc2b6zzK-Ou0UUJVTA3Q5-gr5fnz6d5tHx_XTzNlpHmQrEIeCFJrATTLM1zxSHhXCaCKkZBxlKVaZKSmMu4LDTVjMsyh1gkBZWxklRJPkEPx7vbxn93JrRZbYM2VQXO-C5kaaLSREjRg9MjqBsfQmPKbNvYGpp9Rkl2yC7rs8t-s-sX7obLXV6b4oQPYfX6_aBD0FCVDThtwwlTjPd18FVHbGcrs__HNJu9zf-88AN0UIXL</recordid><startdate>198502</startdate><enddate>198502</enddate><creator>Francis, Susan E.</creator><creator>Joshua, Douglas E.</creator><creator>Exner, Thomas</creator><creator>Kronenberg, Harry</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198502</creationdate><title>Some studies with a monoclonal antibody directed against human fibrinogen</title><author>Francis, Susan E. ; Joshua, Douglas E. ; Exner, Thomas ; Kronenberg, Harry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3692-a3d804962c27bb93a5338561921a8489f75704384fdc1c238fba465d184981983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antibody Specificity</topic><topic>Anticoagulants</topic><topic>Biological and medical sciences</topic><topic>Epitopes</topic><topic>fibrin</topic><topic>Fibrin Fibrinogen Degradation Products - immunology</topic><topic>fibrinogen</topic><topic>Fibrinogen - immunology</topic><topic>Fibrinolysin - pharmacology</topic><topic>Humans</topic><topic>Immunological methods for diagnosis and exploration</topic><topic>Immunopathology</topic><topic>Medical sciences</topic><topic>monoclonal antibody</topic><topic>Other methods</topic><topic>Radioimmunoassay</topic><topic>von Willebrand Diseases - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Francis, Susan E.</creatorcontrib><creatorcontrib>Joshua, Douglas E.</creatorcontrib><creatorcontrib>Exner, Thomas</creatorcontrib><creatorcontrib>Kronenberg, Harry</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Francis, Susan E.</au><au>Joshua, Douglas E.</au><au>Exner, Thomas</au><au>Kronenberg, Harry</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Some studies with a monoclonal antibody directed against human fibrinogen</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>1985-02</date><risdate>1985</risdate><volume>18</volume><issue>2</issue><spage>111</spage><epage>119</epage><pages>111-119</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><coden>AJHEDD</coden><abstract>Some properties of a monoclonal antibody generated against the fibrinogen component of a factor VIII preparation were investigated. The antibody bound with equal affinity in solid phase radioimmunoassays to fibrinogens isolated from both normal patients and patients with von Willebrand disease. It reacted in a sensitive immunoassay of plasma fibrinogen. The specificity of the antibody was confined to the parent molecule with no significant inhibition of fibrinogen binding by the fibrinogen degradation products (FDPs) X, Y, D, or E. The antibody had no significant effect on the activated partial thromboplastin time and prothrombin time of normal plasma. However, it prolonged the thrombin time as determined by the Clauss chronometric fibrinogen method. During fibrinogen lysis by plasmin immunoreactivity of fibrinogen to the antibody was lost at the same rate as the clottable fibrinogen content determined by the Clauss assay. The lack of reactivity of the antibody with FDPs makes it a suitable reagent for investigating plasmin activity as well as studying fibrinogen and fibrin. These findings suggest that the epitope of the antibody lies within the polar protruberance of the carboxy terminal end of the Aα chain of fibrinogen and is destroyed by plasmin cleavage.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>2578730</pmid><doi>10.1002/ajh.2830180202</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0361-8609 |
ispartof | American journal of hematology, 1985-02, Vol.18 (2), p.111-119 |
issn | 0361-8609 1096-8652 |
language | eng |
recordid | cdi_proquest_miscellaneous_75975686 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacology Antibody Specificity Anticoagulants Biological and medical sciences Epitopes fibrin Fibrin Fibrinogen Degradation Products - immunology fibrinogen Fibrinogen - immunology Fibrinolysin - pharmacology Humans Immunological methods for diagnosis and exploration Immunopathology Medical sciences monoclonal antibody Other methods Radioimmunoassay von Willebrand Diseases - immunology |
title | Some studies with a monoclonal antibody directed against human fibrinogen |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A38%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Some%20studies%20with%20a%20monoclonal%20antibody%20directed%20against%20human%20fibrinogen&rft.jtitle=American%20journal%20of%20hematology&rft.au=Francis,%20Susan%20E.&rft.date=1985-02&rft.volume=18&rft.issue=2&rft.spage=111&rft.epage=119&rft.pages=111-119&rft.issn=0361-8609&rft.eissn=1096-8652&rft.coden=AJHEDD&rft_id=info:doi/10.1002/ajh.2830180202&rft_dat=%3Cproquest_cross%3E75975686%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75975686&rft_id=info:pmid/2578730&rfr_iscdi=true |